OTC
38.52USD
+1.05 (+2.80%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
40.5B
P/E
—
EPS
—
Beta
-0.05
52W range
25.3-38.57
Day range
38.45–38.57
Open
38.54
Prev close
37.47
Volume
200
Avg volume
38K
Dividend
0.43
IPO
2012-08-03
https://seekingalpha.com/article/4931746-otsuka-holdings-co-ltd-otsky-discusses-24-month-egfr-results-of-sibeprenlimab-in-iga · 8/6/2026+0.60
https://seekingalpha.com/article/4889946-otsuka-holdings-co-ltd-otsky-m-and-a-call-prepared-remarks-transcript · 4/10/2026+0.80
Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
